(redirected from Dihydroartemisinin)
Also found in: Medical, Wikipedia.
DHADocosahexaenoic Acid
DHADepartment of Home Affairs
DHADubai Health Authority (previously known as DOHMS)
DHADefence Housing Authority
DHADepartment of Humanitarian Affairs (United Nations)
DHADoctor of Health Administration
DHADirectory Harvest Attack
DHADallas Housing Authority
DHADihydroartemisinin (antimalarial drug)
DHADivision of Hearings and Appeals (Wisconsin)
DHACommonwealth Department of Health and Ageing (Australia)
DHADisaster Housing Assistance (FEMA)
DHADetroit Hockey Association (Detroit, MI)
DHADirect Hardware Access
DHADetainee Holding Area
DHADescend, Heartless Angel (Kingdom Hearts game)
DHADoctor of Healthcare Administration
DHADanube Hydro Austria
DHADirect Historic Approach (archaeology)
DhADe-Hydroabietic Acid
DHADependent Housing Area
DHADesign Hazard Analysis
DHADirect Humanitarian Aid
DHADeparture Holding Area
DHADhahran, Saudi Arabia - Dhahran International (Airport Code)
DHADigital Headed Assembly
DHADepartment of Hearings and Appeals
DHADirections for Handling and Administration (clinical trials)
DHADialogues d'Histoire Ancienne (French: Dialogues of Ancient History)
DHADistri Haut Anjou (French firewood business)
DHADavid Higham Associates (UK)
References in periodicals archive ?
Dihydroartemisinin induces autophagy and inhibits the growth of iron-loaded human myeloid leukemia K562 cells via ROS toxicity.
Semi-synthetic derivatives of artemisinin include dihydroartemisinin, artemether, and artesunate.
Artemether Tablets, Artemether Injections, Artesunate Tablets, Dihydroartemisinin Powder for Suspension, and many other Antimalarial products are now in the hands of those that need it most.
The study of the efficacy and safety of oral dihydroartemisinin tablet (cotecxin) on uncomplicated Plasmodium falciparum malaria patients.
6) Drugs consisted of nine antimalarials, to include chloroquine, sulfadoxine-pyrimethamine, mefloquine, amodiaquine, artemether, artesunate, dihydroartemisinin and two artemisinin-based combination therapies (artemether-lumefantrine and artesunate-amodiaquine); two antimycobacterials, to include isoniazid and rifampicin; and two antibiotics, to include ciprofloxacin and erythromycin.
The health organisation has now added a fifth ACT - dihydroartemisinin plus piperaquine - to the previous list of recommended medicines.
Selective cancer cell cytotoxicity from exposure to dihydroartemisinin and hololransterrin.
The study concerned versions of such widely used and trusted medications as sulfadoxine-pyrimethamine, amodiaquine, mefloquine, artesunate, artemether, dihydroartemisinin and artemether-lumefantrine fixed-dose combinations.
These include artemether, artesunate and dihydroartemisinin.
4 mg/kg for dihydroartemisinin and 18 mg/kg for piperaquine once a day for 3 days.
Dihydroartemisinin induces apoptosis in colorectal cancer cells through the mitochondria-dependent pathway.